SENTINEL SPECTRUM 50.1-100LBS- milbemycin oxime, lufenuron, praziquantel tablet, chewable 미국 - 영어 - NLM (National Library of Medicine)

sentinel spectrum 50.1-100lbs- milbemycin oxime, lufenuron, praziquantel tablet, chewable

virbac ah, inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt), lufenuron (unii: 1r754m4918) (lufenuron - unii:1r754m4918), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - milbemycin oxime 23 mg - sentinel spectrum is indicated for the prevention of heartworm disease caused by dirofilaria immitis ; for the prevention and control of flea populations (ctenocephalides felis ); and for the treatment and control of adult roundworm (toxocara canis, toxascaris leonina ), adult hookworm (ancylostoma canium ), adult whipworm (trichuris vulpis), and adult tapeworm (taenia pisiformis, echinococcus multilocularis and echinococcus granulosus ) infections in dogs and puppies, two pounds of body weight or greater and six weeks of age and older. there are no known contraindications to the use of sentinel spectrum.

SENTINEL SPECTRUM 25.1-50LBS- milbemycin oxime, lufenuron, praziquantel tablet, chewable 미국 - 영어 - NLM (National Library of Medicine)

sentinel spectrum 25.1-50lbs- milbemycin oxime, lufenuron, praziquantel tablet, chewable

virbac ah, inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt), lufenuron (unii: 1r754m4918) (lufenuron - unii:1r754m4918), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - milbemycin oxime 11.5 mg - sentinel spectrum is indicated for the prevention of heartworm disease caused by dirofilaria immitis ;for the prevention and control of flea populations (ctenocephalides felis ); and for the treatment and control of adult roundworm (toxocara canis, toxascaris leonina ), adult hookworm (ancylostoma canium ), adult whipworm (trichuris vulpis ), and adult tapeworm (taenia pisiformis, echinococcus multilocularis and echinococcus granulosus ) infections in dogs and puppies, two pounds of body weight or greater and six weeks of age and older. there are no known contraindications to the use of sentinel spectrum.

SENTINEL SPECTRUM 2-8LBS- milbemycin oxime, lufenuron, praziquantel tablet, chewable 미국 - 영어 - NLM (National Library of Medicine)

sentinel spectrum 2-8lbs- milbemycin oxime, lufenuron, praziquantel tablet, chewable

virbac ah, inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt), lufenuron (unii: 1r754m4918) (lufenuron - unii:1r754m4918), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - milbemycin oxime 2.3 mg - sentinel spectrum is indicated for the prevention of heartworm disease caused by dirofilaria immitis ;for the prevention and control of flea populations (ctenocephalides felis ); and for the treatment and control of adult roundworm (toxocara canis, toxascaris leonina ), adult hookworm (ancylostoma canium ), adult whipworm (trichuris vulpis ), and adult tapeworm (taenia pisiformis, echinococcus multilocularis and echinococcus granulosus ) infections in dogs and puppies, two pounds of body weight or greater and six weeks of age and older. there are no known contraindications to the use of sentinel spectrum.

MILBEMITE- milbemycin oxime solution 미국 - 영어 - NLM (National Library of Medicine)

milbemite- milbemycin oxime solution

elanco us inc. - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime 1 mg in 1 ml - milbemite otic solution is indicated for treatment of ear mite (otodectes cynotis ) infestations in cats and kittens four weeks of age and older. effectiveness is maintained throughout the life cycle of the ear mite.

AX PHARMACEUTICAL CORP- milbemycin oxime powder 미국 - 영어 - NLM (National Library of Medicine)

ax pharmaceutical corp- milbemycin oxime powder

ax pharmaceutical corp - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime .99 kg in 1 kg

Milbemycin Oxime 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

milbemycin oxime

zhejiang hisun pharmaceutical co., ltd - milbemycin oxime - unknown - milbemycin oxime antibiotic active 0.0 - active constituent

Milbemycin Oxime 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

milbemycin oxime

virbac (australia) pty ltd - milbemycin oxime - unknown - milbemycin oxime antibiotic active 0.0 - active constituent

Milbemycin oxime 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

milbemycin oxime

boehringer ingelheim animal health australia pty. ltd. - milbemycin oxime - unknown - milbemycin oxime antibiotic active 0.0 - active constituent

MILBEMYCIN OXIME 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

milbemycin oxime

neove pharma australia pty limited - milbemycin oxime - unknown - milbemycin oxime antibiotic active 0.0 - active constituent

Trifexis™  
 (spinosad + milbemycin oxime)  
 Chewable Tablets 미국 - 영어 - NLM (National Library of Medicine)

trifexis™ (spinosad + milbemycin oxime) chewable tablets

elanco us inc, - spinosad (unii: xpa88eap6v) (spinosad - unii:xpa88eap6v), milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - spinosad 140 mg - trifexis is indicated for the prevention of heartworm disease (dirofilaria immitis ). trifexis kills fleas and is indicated for the prevention and treatment of flea infestations (ctenocephalides felis ), and the treatment and control of adult hookworm (ancylostoma caninum ), adult roundworm (toxocara canis and toxascaris leonina ) and adult whipworm (trichuris vulpis ) infections in dogs and puppies 8 weeks of age or older and 5 pounds of body weight or greater. there are no known contraindications to the use of trifexis.